Inside the pool of 7 clinical trials, the types and frequency of prevalent adverse reactions, not including hypoglycemia, have been much like All those mentioned in Desk 1. In a 28 7 days medical trial Mounjaro increased insulin sensitivity and secretion though decreasing levels of glucagon.